Clinical trials
Craniopharyngioma clinical trials
Below are recruiting craniopharyngioma clinical trials, each written for real people, not researchers. We’re tracking 14 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05465174RecruitingPhase 2
Tovorafenib for children and young adults with craniopharyngioma
This trial studies tovorafenib to treat craniopharyngioma in children and young adults. It aims to shrink the tumor or slow its growth, and to learn which patients benefit most and what side effects to expect.
Birmingham, AlabamaAges 1–39 - NCT05233397RecruitingPhase 2
Actemra for children and young adults with craniopharyngioma
This trial studies Actemra (tocilizumab) to slow or shrink adamantinomatous craniopharyngioma, a brain tumor that can recur after treatment. You may be eligible if you’re within the age range and have measurable tumor on scan, with specific rules about prior therapy and recovery.
Aurora, ColoradoAges 1–39 - NCT05286788RecruitingPhase 2
MEKTOVI for children with adamantinomatous craniopharyngioma
This Phase 2 trial tests MEKTOVI® to treat pediatric adamantinomatous craniopharyngioma (a type of brain tumor). It may help shrink or control the tumor after it has come back or grown again.
Aurora, ColoradoAges 1–39 - NCT05525273RecruitingPhase 2
BRAF-mutated papillary craniopharyngioma targeted drug trial
This Phase 2 trial tests a targeted treatment for adults with papillary craniopharyngioma that has a specific BRAF change (V600E). It may help shrink or control the tumor, especially when surgery is not expected to remove it safely.
LundAges 18 years+ - NCT06801756Recruiting
Craniopharyngioma and pregnancy study
This trial looks at how craniopharyngioma, a rare brain tumor, affects pregnancy. Researchers want to learn more about health outcomes for women who have or had this tumor.
ParisAges 18 years+ - NCT06970145RecruitingPhase 1/Phase 2
Anlotinib for recurrent craniopharyngioma
This trial tests if the drug anlotinib can safely and effectively treat recurrent craniopharyngioma, a type of brain tumor. It is for patients whose tumor has come back or grown after previous treatment.
Guangzhou, GuangdongAges 18–75 - NCT07177482Recruiting
Imaging test for a brain tumor before surgery
This trial tests a new imaging method that uses a special dye to highlight a protein called Trop-2 found on some brain tumor cells. The goal is to see if this dye can help doctors see the tumor more clearly before surgery, which may improve surgical planning.
Beijing, Beijing MunicipalityAges 14–80 - NCT05919264RecruitingPhase 1/Phase 2
FOG-001 for advanced solid tumors with certain gene changes
This trial tests a new drug, FOG-001, alone or with other treatments, for people with advanced solid tumors that have specific changes in the WNT pathway genes. It aims to see if the drug can shrink tumors or slow their growth.
Phoenix, ArizonaAges 18 years+ - NCT07712328Enrolling by invitationPhase 4
Desmopressin during complex sellar tumor surgery
This trial tests whether giving desmopressin (a drug that helps the body hold onto water) during surgery can prevent fluid and sodium balance problems in people having complex pituitary or sellar region tumor surgery. It’s designed for those at higher risk of these issues.
ShanghaiAges 18–75 - NCT04648462Recruiting
Proton therapy planning for certain brain tumors
This study builds and tests how proton therapy planning could better protect the brain compared with standard radiation (photon therapy) for adults with certain brain tumors. It may help reduce radiation to sensitive areas like the hippocampus, with the goal of better long-term brain function.
Maastricht, LimburgAges 18 years+ - NCT06299891RecruitingPhase 2
Study of weight loss medication for youth with hypothalamic obesity
This study tests a combination of two medications, phentermine and topiramate, to see if they help young people with hypothalamic obesity lose weight safely. Hypothalamic obesity is rapid weight gain caused by injury to the hypothalamus, often from a brain tumor or its treatment.
Philadelphia, PennsylvaniaAges 6–28 - NCT06874426Recruiting
How nose surgery on the skull base affects smell
This study looks at how having skull base surgery through the nose affects your sense of smell. It helps doctors learn more about changes in smell after this procedure.
Leuven, Vlaams-BrabantAges 18–70 - NCT07316101Recruiting
Anti-fog device for brain tumor surgery through the nose
This trial tests a new anti-fog drainage device used during endoscopic pituitary tumor surgery. The device may help keep the surgeon's view clear and improve drainage after surgery.
Chengdu, SichuanAges 18–75 - NCT03610906Enrolling by invitation
Study of blood/tissue targets in suspected childhood brain tumors
This study looks at biological “targets” (things in the body) to help guide future medical treatments for children and teens with suspected craniopharyngioma. It will collect and analyze tissue samples from planned care to understand what therapies might work best.
Aurora, ColoradoAges 4 weeks–21 years
Hear when a new Craniopharyngioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for craniopharyngioma?
- Yes. Clin2 currently lists 14 recruiting craniopharyngioma studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a craniopharyngioma trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a craniopharyngioma trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.